Active, Not Recruiting
Phase 3
Age: 18Years - 75Years
All Genders
ID04652882
A Multicenter, Double-blind, Randomized Study to Evaluate the Effects of Tasimelteon vs. Placebo in Participants With Delayed Sleep-Wake Phase Disorder DSWPD
Led by Vanda Pharmaceuticals · Updated on 2026-07-27
70
Participants Needed
17
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
This is a multicenter, double-blind, randomized study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon and matching placebo in male and female participants with DSWPD.
CONDITIONS
Brief Title
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here